Kiromic Biopharma, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kiromic Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Kiromic Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.6M, a 18.9% decline year-over-year.
  • Kiromic Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$23.4M, a 8.56% decline year-over-year.
  • Kiromic Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$19.9M, a 35.9% increase from 2022.
  • Kiromic Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$31.1M, a 20.9% decline from 2021.
  • Kiromic Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$25.7M, a 34.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$19.9M +$11.2M +35.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$31.1M -$5.38M -20.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$25.7M -$6.54M -34.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$19.2M -$15.5M -418% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2019 -$3.71M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.